Search

Unraveling Monoamine Receptors Involved in the Action of Typical and Atypical Antipsychotics on Glutamatergic and Serotonergic Transmission in Prefrontal Cortex

Journal: Current Pharmaceutical Design
Volume: 16 Issue: 5 Year: 2010 Page: 502-515
Author(s): Xavier Lopez-Gil, Francesc Artigas, Albert Adell

Journal: Current Medicinal Chemistry
Volume: 17 Issue: 3 Year: 2010 Page: 4538-4550
Author(s): B. Drexler, H. Hentschke, B. Antkowiak, C. Grasshoff

Cognitive Improvement by Activation of α7 Nicotinic Acetylcholine Receptors: From Animal Models to Human Pathophysiology

Journal: Current Pharmaceutical Design
Volume: 16 Issue: 3 Year: 2010 Page: 323-343
Author(s): Morten S. Thomsen, Henrik H. Hansen, Mikkelsen B. Timmerman, Jens D. Mikkelsen

Therapeutic Utility of NK3 Receptor Antagonists for the Treatment of Schizophrenia

Journal: Current Pharmaceutical Design
Volume: 16 Issue: 3 Year: 2010 Page: 344-357
Author(s): Lee A. Dawson, Paul W. Smith

Riluzole, Neuroprotection and Amyotrophic Lateral Sclerosis

Journal: Current Medicinal Chemistry
Volume: 17 Issue: 1 Year: 2010 Page: 1942-1959
Author(s): B.C. Cheah, S. Vucic, A. V. Krishnan, M.C. Kiernan

Neuropeptides and Other Chemical Mediators, and the Role of Anti-inflammatory Drugs in Primary Headaches

Journal: Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Volume: 9 Issue: 3 Year: 2010 Page: 170-188
Author(s): Mohtashem Samsam, Rafael Covenas, Raheleh Ahangari, Javier Yajeya